Analysts and calls -- US Bancorp Piper Jaffray Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Analysts and calls -- US Bancorp Piper Jaffray

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (11)	6/27/2003 4:39:19 PM
From: Icebrg	Read Replies (1) of 22

Gen-Probe initiated with "strong buy" - update Updated Friday, June 27, 2003 1:43:34 PM ET US Bancorp Piper Jaffray NEW YORK, June 27 (New Ratings) — Analyst Thomas Wei of US Bancorp Piper Jaffray initiates coverage of Gen-Probe Inc (GPRO) with a "strong buy" rating. The target price is set to $56. In a research note published this afternoon, the analyst mentions that Gen-Probe is attractively positioned to benefit from a large growth opportunity in the blood screening market in partnership with Chiron Corporation. In addition, the analyst anticipates an accelerated operating margins growth for the company over the coming years. US Bancorp Piper Jaffray expects the forthcoming royalty gains from Chiron to significantly boost Gen-Probe's earnings gains in 2003. [The stock opened at 42.34 and closed 84 cents lower]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next